Why are binding-site models more complicated than molecules?
dc.contributor.author | Crippen, Gordon M. | en_US |
dc.contributor.author | Richardson, Wendy W. | en_US |
dc.contributor.author | Bradley, M. P. | en_US |
dc.date.accessioned | 2006-09-08T21:21:03Z | |
dc.date.available | 2006-09-08T21:21:03Z | |
dc.date.issued | 1993-12 | en_US |
dc.identifier.citation | Crippen, G. M.; Bradley, M. P.; Richardson, W. W.; (1993). "Why are binding-site models more complicated than molecules?." Perspectives in Drug Discovery and Design 1(2): 321-328. <http://hdl.handle.net/2027.42/43355> | en_US |
dc.identifier.issn | 1573-9023 | en_US |
dc.identifier.issn | 0928-2866 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/43355 | |
dc.description.abstract | A commonly occurring problem in drug development is that the binding affinities for a few compounds to a particular binding site on some protein have been measured, but the crystal structure for that protein is not available. Quantitative structure-activity methods attempt to empirically correlate the binding data with various features of the chemical structures of the drug molecules, so that one can predict the binding of novel compounds and thus aid the search for improved drugs. A common feature of nearly all these methods, however, is that they rely—implicitly or explicitly—on a guess as to the positioning of each molecule when bound to the common site. If one instead assumes that each molecule is free to seek out its optimal positioning in the site, then correlating the observed activity to molecular structure becomes more difficult, and can lead to surprisingly complicated site models. Here we show with some extremely simple artificial examples how this complexity necessarily arises. | en_US |
dc.format.extent | 607057 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; ESCOM Science Publishers B.V. ; Springer Science+Business Media | en_US |
dc.subject.other | Pharmacy | en_US |
dc.subject.other | Pharmacy | en_US |
dc.subject.other | Biotechnology | en_US |
dc.subject.other | Polymer Sciences | en_US |
dc.subject.other | Biochemistry, General | en_US |
dc.subject.other | Animal Anatomy / Morphology / Histology | en_US |
dc.subject.other | Quantitative Structure-activity Relations | en_US |
dc.subject.other | Voronoi Diagrams | en_US |
dc.subject.other | Receptor-site Mapping | en_US |
dc.subject.other | Pharmacophore | en_US |
dc.title | Why are binding-site models more complicated than molecules? | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Materials Science and Engineering | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, 48109, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, 48109, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, 48109, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/43355/1/11091_2005_Article_BF02174532.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF02174532 | en_US |
dc.identifier.source | Perspectives in Drug Discovery and Design | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.